Noticeably, patients with GBM without IDH mutation exhibit increased SHC1 expression in CGGA datasets (Fig. 4D–F); whereas G_CIMP positive GBM have lower SHC1 expression in GSE108747 and GSE16011 datasets (Fig. 4G,H). This evidence concerns the gene SHC1 and glioblastoma.